Catamaran is a biotechnology company focused on developing novel CAR-NK cell therapies for the treatment of various cancer types, especially solid tumors. They harness the natural cancer-fighting properties of NK cells, utilizing synthetic biology and non-viral cell engineering to create transformative off-the-shelf CAR-NK cell therapies.